Related Experiment Video
Updated: Jul 19, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Dual functional therapeutics: mitigating bacterial infection and associated inflammation
Yash Acharya1, Kashish Kumar Taneja1, Jayanta Haldar1,2
1Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Jakkur Bengaluru 560064 Karnataka India jayanta@jncasr.ac.in.
Antimicrobial resistance and persistent infections require new treatments. This review explores dual-action therapeutics that fight bacteria and reduce harmful inflammation, offering hope for complex infections.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Antimicrobial resistance and persistent infections complicate clinical treatments.
- Bacterial infections trigger host immune responses, leading to inflammation that can cause sepsis.
- The interplay between infection and inflammation impacts therapeutic efficacy.
Purpose of the Study:
- To review dual-functional antibacterial therapeutics with immunomodulatory properties.
- To highlight agents that combat bacterial infections while regulating inflammation.
- To explore novel therapeutic strategies for infection-associated inflammation.
Main Methods:
- Literature review of scientific publications.
- Analysis of existing research on antibacterial agents with immunomodulatory functions.
- Identification of key therapeutic classes, including host defense peptides and peptidomimetics.
Main Results:
- Several classes of antibiotics possess both antibacterial and immunomodulatory activities.
- Host defense peptides and their synthetic analogs are promising dual-function candidates.
- Specific peptidomimetics demonstrate combined antibacterial and anti-inflammatory effects.
Conclusions:
- Dual-functional therapeutics offer a promising approach to treating complex bacterial infections with associated inflammation.
- Further development of agents with combined antibacterial and immunomodulatory properties is warranted.
- Host defense peptides and peptidomimetics represent key areas for future therapeutic innovation.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

